Hudson Bay Capital Management’s Editas Medicine EDIT Stock Holding History

Hudson Bay Capital Management’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-20,000	Closed	-$455K	–	753
2018 Q4	$455K	Sell	20,000 -90,000	-82%	-$2.45M	0.01%	698
2018 Q3	$3.5M	Buy	110,000 +10,000	+10%	+$323K	0.04%	365
2018 Q2	$3.58M	Buy	100,000 +40,000	+67%	+$1.42M	0.05%	370
2018 Q1	$1.99M	Hold	60,000	–	–	0.04%	457
2017 Q4	$1.84M	Sell	60,000 -40,000	-40%	-$1.01M	0.04%	331
2017 Q3	$2.4M	Hold	100,000	–	–	0.06%	227
2017 Q2	$1.68M	Hold	100,000	–	–	0.03%	358
2017 Q1	$2.23M	Buy	+100,000	New	+$2.07M	0.03%	438

Other funds holding EDIT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

OTPPB

Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return

Hudson Bay Capital Management's EDIT Position: Q1 2019 in Review

Hudson Bay Capital Management sold out of Editas Medicine (EDIT) in Q1 2019, closing a stake of 20,000 shares — an estimated $455K sold.

Hudson Bay Capital Management first reported a position in EDIT in Q1 2017 and held it in 8 quarters. The position peaked at $3.58M in Q2 2018. 201 funds tracked by Wall St. Rank hold EDIT as of Q1 2019.

Hudson Bay Capital Management reported no remaining Editas Medicine position as of Q1 2019 after selling out during the quarter.
Hudson Bay Capital Management sold 20,000 Editas Medicine shares in Q1 2019, an estimated $455K.
Hudson Bay Capital Management first reported a position in Editas Medicine in Q1 2017 and held it in 8 quarters.
Hudson Bay Capital Management's Editas Medicine position peaked at $3.58M in Q2 2018.
201 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2019.

Based on Hudson Bay Capital Management's 13F filing for Q1 2019, filed 15 May 2019.